Investment
Features
FeesSafety
Academy
More
Pluang+

Trillium sells its U.S. pumps business to Crane Company for $240M to focus on portfolio growth.

Company Fundamentals
14 Sep 2026
PRNewsWire
View Source
Bullish
Trillium sells its U.S. pumps business to Crane Company for $240M to focus on portfolio growth.

Trillium Flow Technologies has agreed to sell its U.S. pumps business, Trillium Pumps US (TPU), to Crane Company for about $240 million. TPU serves municipal water and wastewater markets with well-known brands and offers critical pumping solutions with ongoing service demand. The sale is part of Trillium's strategy to refine its portfolio and position its businesses for long-term success. The transaction is expected to close later this year, pending regulatory approvals.

More News

CAVA COO Douglas Thompson buys 6,500 shares worth $432,000

CAVA COO Douglas Thompson buys 6,500 shares worth $432,000

Douglas Thompson, Chief Operating Officer of CAVA, purchased 6,500 shares of the company valued at $432,000. This insider buying could signal confidence in CAVA's future prospects. Investors often view such purchases as a positive sign, potentially i...

Market News
Bullish
2 hours ago
Ucore secures additional $4.6M to expand rare earth separation for US defense supply chains.

Ucore secures additional $4.6M to expand rare earth separation for US defense supply chains.

Ucore Rare Metals received an additional $4.6 million from the U.S. Department of War to expand its RapidSX™ rare earth separation program, focusing on samarium and gadolinium processing at its Louisiana facility. These materials are critical for U.S...

Market News
Bullish
4 hours ago
Investigation launched into ADMA Biologics for possible revenue inflation via channel-stuffing.

Investigation launched into ADMA Biologics for possible revenue inflation via channel-stuffing.

Berger Montague PC is investigating ADMA Biologics' Board for potential breaches of fiduciary duty related to alleged channel-stuffing to boost revenue despite falling demand for its main product, ASCENIV. This legal probe could impact shareholder co...

Market News
Bearish
4 hours ago
Pfizer's 6% dividend yield faces risks from patent expirations and tight cash flow.

Pfizer's 6% dividend yield faces risks from patent expirations and tight cash flow.

Pfizer offers a high 6.19% dividend yield, attractive to income investors, but the sustainability of this payout is uncertain due to upcoming patent expirations that threaten revenue. The company covers dividends with free cash flow, but the margin i...

Market News
Neutral
4 hours ago
Memory stocks plunge as AI leaders call for slower AI development pace.

Memory stocks plunge as AI leaders call for slower AI development pace.

Memory stocks like Micron, SanDisk, and SK Hynix dropped 6-7% following calls from Anthropic and OpenAI CEOs to slow AI development. These stocks are heavily tied to AI infrastructure demand, so investor concerns about a slowdown in AI training have ...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App